Literature DB >> 27759931

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Robert A Adler, Ghada El-Hajj Fuleihan, Douglas C Bauer, Pauline M Camacho, Bart L Clarke, Gregory A Clines, Juliet E Compston, Matthew T Drake, Beatrice J Edwards, Murray J Favus, Susan L Greenspan, Ross McKinney, Robert J Pignolo, Deborah E Sellmeyer.   

Abstract

Entities:  

Year:  2016        PMID： 27759931     DOI： 10.1002/jbmr.2918

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  20 in total

1.  Duration of anti-resorptive therapy for osteoporosis.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

2.  Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting.

Authors:  E S LeBlanc; A G Rosales; H K Genant; R M Dell; D M Friess; D L Boardman; A C Santora; D C Bauer; A E de Papp; D M Black; E S Orwoll
Journal:  Osteoporos Int       Date:  2019-02-26       Impact factor: 4.507

3.  Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk.

Authors:  Jeffrey R Curtis; Kenneth G Saag; Tarun Arora; Nicole C Wright; Huifeng Yun; Shanette Daigle; Robert Matthews; Elizabeth Delzell
Journal:  Med Care       Date:  2020-05       Impact factor: 2.983

4.  Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.

Authors:  M Kamimura; Y Nakamura; S Ikegami; S Uchiyama; H Kato; A Taguchi
Journal:  Osteoporos Int       Date:  2017-01-27       Impact factor: 4.507

5.  Osteoporosis Management in Ankylosing Spondylitis.

Authors:  Alicia M Hinze; Grant H Louie
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-10-05

6.  Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.

Authors:  Rebecca L Drieling; Andrea Z LaCroix; Shirley A A Beresford; Denise M Boudreau; Charles Kooperberg; Rowan T Chlebowski; Marcia G Ko; Susan R Heckbert
Journal:  J Am Geriatr Soc       Date:  2017-05-29       Impact factor: 5.562

7.  PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.

Authors:  Christopher M Bartlow; Megan E Oest; Kenneth A Mann; Nicholas D Zimmerman; Bilal B Butt; Timothy A Damron
Journal:  J Orthop Res       Date:  2016-10-03       Impact factor: 3.494

8.  Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Authors:  Beatrice J Edwards; Ming Sun; Xiaotao Zhang; Holly M Holmes; Juhee Song; Peter Khalil; Meghan Karuturi; Jay B Shah; Colin P Dinney; Robert F Gagel; Vicente Valero; Richard E Champlin; Debasish Tripathy; William A Murphy
Journal:  Support Care Cancer       Date:  2017-12-02       Impact factor: 3.603

9.  High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.

Authors:  Hiroe Sato; Naoki Kondo; Ayako Wakamatsu; Daisuke Kobayashi; Takeshi Nakatsue; Yoko Wada; Takeshi Kuroda; Yoshiki Suzuki; Masaaki Nakano; Naoto Endo; Ichiei Narita
Journal:  Rheumatol Int       Date:  2019-08-05       Impact factor: 2.631

10.  Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study.

Authors:  Martin Salgueiro; Michael Stribos; Li Fang Zhang; Mark Stevens; Mohamed E Awad; Mohammed Elsalanty
Journal:  EPMA J       Date:  2019-01-24       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.